Table 1 Demographic, clinical, and intervention characteristics for patients with data at baseline and post-intervention (N = 16)
Variable | Category | Statistic |
|---|---|---|
Age in years, mean (SD, range) |  | 71.25 (4.5, 65.0–80.0) |
Gender, n (%) | Male | 10 (62.5) |
| Â | Female | 6 (37.5) |
Education, n (%) | High school or less | 2 (12.5) |
| Â | Some college/post high school training | 4 (25.0) |
| Â | College graduate | 4 (25.0) |
| Â | Post-graduate | 5 (31.3) |
| Â | Other/prefer not to say | 1 (6.3) |
Martial status, n (%) | Married | 10 (62.5) |
| Â | Long term significant other | 1 (6.3) |
| Â | Divorced or widowed | 5 (31.3) |
| Â | Single | 5 (31.3) |
Cancer type, n (%) | Acute Myeloid Leukemia | 9 (56.3) |
| Â | Chronic myelomonocytic leukemia | 1 (6.3) |
| Â | Myelodysplastic Syndrome | 6 (37.5) |
Chemotherapy cycle at exercise initiation, n (%) | 1 | 3 (18.8) |
| Â | 2 | 5 (31.3) |
| Â | 3 | 4 (25.0) |
| Â | 4 | 1 (6.3) |
| Â | 5 or more | 3 (18.8) |
Days/week of resistance exercise, mean (SD, range)* | Â | 3.46 (2.2, 0.1-7.0) |
Minutes per bout of resistance exercise, mean (SD, range)* |  | 26.6 (10.7, 8.3–46.1) |
Average RPE during resistance exercise, mean (SD, range)* |  | 3.4 (1.2, 0.8–5.6) |
Average daily steps at baseline, mean (SD, range) | Â | 3005.0 (1629.6, 649.8-6546.4) |
Average daily steps at post-intervention, mean (SD, range) | Â | 3757.8 (2762.2, 307.3-10554.9) |
Average increase in daily steps, mean (SD, range) | Â | 752.8 (1596.9, -1099.8-4602.8) |